BFRA
Price:
$2.67
Market Cap:
$8.86M
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell car...[Read more]
Industry
Biotechnology
IPO Date
2018-02-14
Stock Exchange
NASDAQ
Ticker
BFRA
According to Biofrontera AG’s latest financial reports and current stock price. The company's current ROE is -1151.42%. This represents a change of 402.74% compared to the average of -229.03% of the last 4 quarters.
The mean historical ROE of Biofrontera AG over the last ten years is -218.01%. The current -1151.42% ROE has changed 428.15% with respect to the historical average. Over the past ten years (40 quarters), BFRA's ROE was at its highest in in the June 2021 quarter at 267.81%. The ROE was at its lowest in in the March 2025 quarter at -896.16%.
Average
-218.01%
Median
-260.57%
Minimum
-420.01%
Maximum
36.39%
Discovering the peaks and valleys of Biofrontera AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.57%
Maximum Annual ROE = 36.39%
Minimum Annual Increase = -618.06%
Minimum Annual ROE = -420.01%
| Year | ROE | Change |
|---|---|---|
| 2024 | -400.61% | -4.62% |
| 2023 | -420.01% | 15.57% |
| 2022 | -2.68% | -99.19% |
| 2021 | -332.62% | 76.44% |
| 2020 | -188.52% | -618.06% |
The current ROE of Biofrontera AG (BFRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-274.43%
5-year avg
-268.89%
10-year avg
-218.01%
Biofrontera AG’s ROE is greater than IGM Biosciences, Inc. (-93.35%), greater than Landos Biopharma, Inc. (-61.86%), greater than Jade Biosciences, Inc. (-49.03%), greater than Quince Therapeutics, Inc. (-186.08%), greater than Berkeley Lights, Inc. (-55.98%), greater than Surface Oncology, Inc. (-61.52%), greater than Heat Biologics, Inc. (-1764.70%), greater than Miromatrix Medical Inc. (-74.80%), greater than Achilles Therapeutics plc (-32.91%), less than Reneo Pharmaceuticals, Inc. (38.83%),
| Company | ROE | Market cap |
|---|---|---|
| -93.35% | $77.50M | |
| -61.86% | $71.68M | |
| -49.03% | $540.28M | |
| -186.08% | $193.77M | |
| -55.98% | $86.61M | |
| -61.52% | $65.08M | |
| -1764.70% | $61.07M | |
| -74.80% | $92.95M | |
| -32.91% | $60.83M | |
| 38.83% | $60.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biofrontera AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biofrontera AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biofrontera AG's ROE?
How is the ROE calculated for Biofrontera AG (BFRA)?
What is the highest ROE for Biofrontera AG (BFRA)?
What is the 3-year average ROE for Biofrontera AG (BFRA)?
What is the 5-year average ROE for Biofrontera AG (BFRA)?
How does the current ROE for Biofrontera AG (BFRA) compare to its historical average?